217 related articles for article (PubMed ID: 22898640)
1. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
[TBL] [Abstract][Full Text] [Related]
2. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts.
Di Cello F; Hillion J; Kowalski J; Ronnett BM; Aderinto A; Huso DL; Resar LM
Mol Cancer Ther; 2008 Jul; 7(7):2090-5. PubMed ID: 18645019
[TBL] [Abstract][Full Text] [Related]
4. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
Liau SS; Jazag A; Whang EE
Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ
Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949
[TBL] [Abstract][Full Text] [Related]
6. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
[TBL] [Abstract][Full Text] [Related]
8. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
9. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
[TBL] [Abstract][Full Text] [Related]
11. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
Ding X; Zhu C; Qiang H; Zhou X; Zhou G
Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
[TBL] [Abstract][Full Text] [Related]
12. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
Xu G; Wu K; Wang XP; Zhao S
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.
Tan Y; Xu F; Xu L; Cui J
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970695
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
[TBL] [Abstract][Full Text] [Related]
16. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
[TBL] [Abstract][Full Text] [Related]
17. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
18. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
[TBL] [Abstract][Full Text] [Related]
19. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
Yuan S; Pan Q; Fu C; Bi Z
Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.
Zhong J; Liu C; Zhang QH; Chen L; Shen YY; Chen YJ; Zeng X; Zu XY; Cao RX
Int J Oncol; 2017 May; 50(5):1567-1578. PubMed ID: 28393241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
